SCHEMBL5331634

SCHEMBL5331634

COc1ccc2c(c1)C(O)n1c-2cc2c(C3CCCCC3)cc(C(=O)O)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.43
NSD2 O96028 1/20 0.37
NSD1 Q96L73 1/20 0.37
NSD3 Q9BZ95 1/20 0.37
LPAR5 Q9H1C0 1/20 0.37
HPSE Q9Y251 1/20 0.37
MEN1 O00255 1/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.35
BRD4 O60885 1/20 0.35
CNR2 P34972 1/20 0.34
MAPKAPK2 P49137 1/20 0.34
MAPKAPK5 Q8IW41 1/20 0.34
KCNH2 Q12809 5/20 0.34
NR1I2 O75469 4/20 0.33
KDM4E B2RXH2 1/20 0.33
MTNR1A P48039 1/20 0.33
MTNR1B P49286 1/20 0.33
CYP3A4 P08684 1/20 0.33
SCN5A Q14524 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3706594 0.84 KCNH2 (0.48) PTGDR2KCNH2NR1I2CYP3A4SCN5A
SCHEMBL3842623 0.83 KMO (0.38) PTGDR2SCN5A
SCHEMBL5341238 0.81 KMT2A (0.36) PTGDR2NSD2NSD1NSD3LPAR5
SCHEMBL5927622 0.80 KCNH2 (0.46) PTGDR2MEN1GAAKMT2ACNR2
SCHEMBL3871757 0.78 KMT2A (0.37) PTGDR2MEN1GAAKMT2AKDM4E
SCHEMBL14253860 0.73 KCNH2 (0.47) PTGDR2CNR2KCNH2NR1I2CYP3A4
SCHEMBL3907051 0.73 KCNH2 (0.47) PTGDR2CNR2KCNH2NR1I2CYP3A4
SCHEMBL3857111 0.72 KCNH2 (0.47) PTGDR2BRD4KCNH2NR1I2CYP3A4
SCHEMBL5927627 0.69 KDM4E (0.40) MEN1GAAKMT2AKDM4ECYP3A4
SCHEMBL2637665 0.68 NR1I2 (0.64) KCNH2NR1I2CYP3A4SCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007033175-A1 INDOLOBENZAZEPINE HCV NS5B INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-03-22 WO disclosed